Compare Stocks

Hospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.

Voya Natural Resources Equity Income Fund is a closed-ended equity mutual fund launched by Voya Investment Management LLC. The fund is co-managed by Voya Investments, LLC and Voya Investment Management Co. LLC. It invests in the public equity markets of North America. The fund seeks to invest in stocks of companies operating in the energy, natural resources, and basic materials industries. It primarily invests in growth and value stocks of companies. The fund also invests through derivatives linked to the equity securities such as call options. It employs fundamental analysis with proprietary stock selection screens, focusing on such factors as cash flows, earnings, price-to-book ratios, superior capital allocation, and strong competitive position, and operations to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P North American Natural Resources Sector Index. It was formerly known as ING Risk Managed Natural Resources Fund. Voya Natural Resources Equity Income Fund was formed on October 24, 2006 and is domiciled in the United States.